JPH02215793A - Alkylation of nucleoside - Google Patents
Alkylation of nucleosideInfo
- Publication number
- JPH02215793A JPH02215793A JP3574689A JP3574689A JPH02215793A JP H02215793 A JPH02215793 A JP H02215793A JP 3574689 A JP3574689 A JP 3574689A JP 3574689 A JP3574689 A JP 3574689A JP H02215793 A JPH02215793 A JP H02215793A
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- nucleoside
- halogenonucleoside
- chloroform
- heated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002777 nucleoside Substances 0.000 title claims abstract description 12
- 150000003833 nucleoside derivatives Chemical class 0.000 title abstract description 4
- 230000029936 alkylation Effects 0.000 title abstract description 3
- 238000005804 alkylation reaction Methods 0.000 title abstract description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000003054 catalyst Substances 0.000 claims abstract description 16
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 28
- 125000003835 nucleoside group Chemical group 0.000 claims description 8
- 230000002152 alkylating effect Effects 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 abstract description 18
- 238000010992 reflux Methods 0.000 abstract description 17
- 239000002904 solvent Substances 0.000 abstract description 14
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 abstract description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 2
- 239000002212 purine nucleoside Substances 0.000 abstract description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 48
- 238000006243 chemical reaction Methods 0.000 description 38
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 22
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 20
- 239000002994 raw material Substances 0.000 description 20
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 15
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 12
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 12
- 235000011130 ammonium sulphate Nutrition 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 235000019270 ammonium chloride Nutrition 0.000 description 10
- 239000002342 ribonucleoside Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- -1 iron ions Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 230000008034 disappearance Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 5
- 239000012300 argon atmosphere Substances 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 101100028920 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cfp gene Proteins 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002718 pyrimidine nucleoside Substances 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- ZPQXPWPLGNNODE-ZRFIDHNTSA-N (2R,3R,4S,5R)-2-(6-amino-2-propylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C(CC)C=1N=C(C=2N=CN([C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)C2N1)N ZPQXPWPLGNNODE-ZRFIDHNTSA-N 0.000 description 1
- TXWHPSZYRUHEGT-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(2-amino-6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C12=NC(N)=NC(Cl)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O TXWHPSZYRUHEGT-UUOKFMHZSA-N 0.000 description 1
- PGHYIISMDPKFKH-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(6-amino-2-bromopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC(Br)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O PGHYIISMDPKFKH-UUOKFMHZSA-N 0.000 description 1
- COQHOBWLVLQVTK-FRJWGUMJSA-N (2r,3r,4s,5r)-2-(6-amino-2-butylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C12=NC(CCCC)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O COQHOBWLVLQVTK-FRJWGUMJSA-N 0.000 description 1
- VFZXAVDWAOZOPF-JJNLEZRASA-N (2r,3r,4s,5r)-2-(6-amino-2-ethylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C12=NC(CC)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VFZXAVDWAOZOPF-JJNLEZRASA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OTACXOORCUVHRF-PNHWDRBUSA-N 1-[(2r,3r,4s,5r)-2-ethyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1=CC(=O)NC(=O)N1[C@]1(CC)O[C@H](CO)[C@@H](O)[C@H]1O OTACXOORCUVHRF-PNHWDRBUSA-N 0.000 description 1
- GZEFTKHSACGIBG-UGKPPGOTSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-propyloxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1=CC(=O)NC(=O)N1[C@]1(CCC)O[C@H](CO)[C@@H](O)[C@H]1O GZEFTKHSACGIBG-UGKPPGOTSA-N 0.000 description 1
- LNVBVDVUTCPLIZ-FDDDBJFASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-ethylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LNVBVDVUTCPLIZ-FDDDBJFASA-N 0.000 description 1
- RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
- AINAVEKHKYYDMI-KQYNXXCUSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-3h-purin-6-one Chemical compound CC1=NC(C(NC(N)=N2)=O)=C2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O AINAVEKHKYYDMI-KQYNXXCUSA-N 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VJUPMOPLUQHMLE-UUOKFMHZSA-N 8-Bromoadenosine Chemical class BrC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VJUPMOPLUQHMLE-UUOKFMHZSA-N 0.000 description 1
- ASUCSHXLTWZYBA-UMMCILCDSA-N 8-Bromoguanosine Chemical compound C1=2NC(N)=NC(=O)C=2N=C(Br)N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ASUCSHXLTWZYBA-UMMCILCDSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- 241001006154 Phara Species 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- WXNOJTUTEXAZLD-UHFFFAOYSA-L benzonitrile;dichloropalladium Chemical compound Cl[Pd]Cl.N#CC1=CC=CC=C1.N#CC1=CC=CC=C1 WXNOJTUTEXAZLD-UHFFFAOYSA-L 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- YSAWTWBSJQRSTA-UHFFFAOYSA-N ethyl 2-(7h-purin-2-yl)acetate Chemical compound CCOC(=O)CC1=NC=C2NC=NC2=N1 YSAWTWBSJQRSTA-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- SQBBHCOIQXKPHL-UHFFFAOYSA-N tributylalumane Chemical compound CCCC[Al](CCCC)CCCC SQBBHCOIQXKPHL-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- HELJHQMKIXWTNN-UHFFFAOYSA-N tricyclopropylalumane Chemical compound C1CC1[Al](C1CC1)C1CC1 HELJHQMKIXWTNN-UHFFFAOYSA-N 0.000 description 1
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 description 1
- MCULRUJILOGHCJ-UHFFFAOYSA-N triisobutylaluminium Chemical compound CC(C)C[Al](CC(C)C)CC(C)C MCULRUJILOGHCJ-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CNWZYDSEVLFSMS-UHFFFAOYSA-N tripropylalumane Chemical compound CCC[Al](CCC)CCC CNWZYDSEVLFSMS-UHFFFAOYSA-N 0.000 description 1
- RTAKQLTYPVIOBZ-UHFFFAOYSA-N tritert-butylalumane Chemical compound CC(C)(C)[Al](C(C)(C)C)C(C)(C)C RTAKQLTYPVIOBZ-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、ヌクレオシドのアルキル化方法に関するもの
である。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for alkylating nucleosides.
天然型ヌクレオシドを化学的に修飾することは。 Chemically modifying naturally occurring nucleosides.
生物活性的に有益な新規な化合物を取得するための必須
手段である。It is an essential means to obtain new biologically active compounds.
従来、プリンヌクレオシドの所望の部位をアルキル化す
る方法としては、■t−ブチルヒドロペルオキシドと2
価の鉄イオンを用いる方法(Tatrahadron、
30.2677 (1974) )、■グリニアール
試薬を用いる方法(TetrahedronLett、
、 3土、3159 (1979))、■エトキシカル
ボニルメチルプリンヌレオシドを脱カルボキシル基反応
に付す方法((:he*、Phara、Bull、 。Conventionally, as a method for alkylating a desired site of a purine nucleoside,
Method using valent iron ions (Tatrahadron,
30.2677 (1974)), ■Method using Grignard reagent (Tetrahedron Lett,
, 3 Sat., 3159 (1979)), ■ A method of subjecting ethoxycarbonylmethylpurine nureoside to a decarboxylation reaction ((:he*, Phara, Bull, ).
33.3263 (1985))、■リチウムジイソプ
ロピルアミド(LDA)を用いてヌクレオシドをリチウ
ム化した後、メチル化する方法(ChaIl。33.3263 (1985)), ■ A method in which nucleosides are lithiated using lithium diisopropylamide (LDA) and then methylated (ChaIl.
Pharm、Bull、、 35.72 (1987)
)などが知られている。Pharm, Bull, 35.72 (1987)
) etc. are known.
一方、ピリミジンヌクレオシドの所望の部位をアルキル
化する方法としては、■ハロゲノマーキュリウリジンと
エチレンまたは塩化アリルをパラジウム触媒の存在下反
応させて、1−メトキシエチルウリジンまたはアリルウ
リジンを得、これを水添分解または水添によりエチルウ
リジンまたはプロピルウリジンを得る方法(J、Am、
Chew+、Soc、。On the other hand, as a method for alkylating a desired site of a pyrimidine nucleoside, Method for obtaining ethyl uridine or propyl uridine by decomposition or hydrogenation (J, Am,
Chew+, Soc.
100、 8106 (1978) 、 J、O
rg、Ches、。100, 8106 (1978), J.O.
rg, Ches,.
43.2870 (1978))、■p−トリルチオメ
チルウリジンをラネーニック°ルを用いて還元する方法
(J、Cham、Soc、、 Chem、Commun
、、 877(1983) 、 5ynthssis、
259 (1982))、■2’ 、3’ 、5’−
トリス−0−(テトラブチルジメチルシリル)ウリジン
を第2級ブチルリチウムとテトラメチルエチレンジアミ
ンを用いてリチウム化後、親電子試薬を反応させる方法
(Terahadron Lett、 、 28.87
(1987) )が報告されている。43.2870 (1978)), ■Method for reducing p-tolylthiomethyluridine using Raney nickel (J, Cham, Soc, Chem, Commun.
,, 877 (1983), 5ynthssis,
259 (1982)), ■2', 3', 5'-
A method in which tris-0-(tetrabutyldimethylsilyl)uridine is lithiated using secondary butyllithium and tetramethylethylenediamine and then reacted with an electrophilic reagent (Terahadron Lett, 28.87
(1987) ) have been reported.
従来の方法は、反応工程が長く、満足いく収率が得られ
なかったり、アルキル基を導入しようとする以外の部位
がアルキル化された副反応生成物を生じ、満足いく方法
ではなかった。たとえば、上記従来方法の中でグリニア
ール試薬を用いる力士
法は、メール化のみが進行し、しかも目的生成物の収率
が低く、実用的な方法とはいえない。Conventional methods are unsatisfactory because the reaction steps are long and a satisfactory yield cannot be obtained, or side reaction products are produced in which sites other than those to which the alkyl group is intended to be introduced are alkylated. For example, among the above-mentioned conventional methods, the Sumo wrestler method using a Grignard reagent only progresses into mail formation, and the yield of the target product is low, so it cannot be said to be a practical method.
本発明者らは、ヌクレオシドの新規なアルキル化法に関
し研究を重ねた結果、原料化合物とじてアルキル基を導
入しようとする部位をハロゲン化したハロゲノヌクレオ
シドを用い、該原料化合物とトリアルキルアルミニウム
試薬とをパラジウム触媒の存在下反応させるという極め
て簡便な方法により目的化合物を収率よく調製できるこ
とを見い出し1本発明を完成させた。As a result of repeated research on a novel alkylation method for nucleosides, the present inventors have discovered that using a raw material compound and a halogenonucleoside in which the site into which an alkyl group is to be introduced is halogenated, the raw material compound and a trialkylaluminum reagent are combined. The present invention has been completed based on the discovery that the target compound can be prepared in good yield by an extremely simple method of reacting in the presence of a palladium catalyst.
すなわち1本発明は、ヌクレオシドをアルキル化する方
法であって、アルキル基を導入する部位をハロゲン化し
たハロゲノヌクレオシドとトリアルキルアルミニウム試
薬とをパラジウム触媒の存在下反応させることを特徴と
するヌクレオシドのアルキル化方法を提供するものであ
る。Specifically, the present invention provides a method for alkylating nucleosides, which comprises reacting a halogenonucleoside whose site for introducing an alkyl group is halogenated with a trialkylaluminium reagent in the presence of a palladium catalyst. This method provides a method for
以下、本発明の詳細な説明する。The present invention will be explained in detail below.
化したハロゲノヌクレオシドである。原料化合物中のハ
ロゲンとしては、塩素、臭素、ヨウ素を例示することが
できるが、特に反応性の高い臭素またはヨウ素を有する
ものが原料化合物として好ましい、このようなハロゲノ
ヌクレオシドは、ハロゲノプリンヌクレオシド、ハロゲ
ノピリミジンヌクレオシドなどを例示することができる
。このようなハロゲノヌクレオシドのうち糖部がリボフ
ラノシル残基を有するものを具体的に例示すれば。It is a halogenonucleoside. Examples of halogens in the raw material compound include chlorine, bromine, and iodine, but those containing highly reactive bromine or iodine are particularly preferred as raw material compounds. Examples include pyrimidine nucleosides. Among such halogenonucleosides, those having a ribofuranosyl residue in the sugar moiety are specifically exemplified.
ハロゲノプリンリボヌクレオシドとしては、8−ハロゲ
ノプリンリボヌクレオシド(たとえば、8−ハロゲノア
デノシン、8−ハロゲノグアノシン、8−ハロゲノイノ
シン、8−ハロゲノキサントシンなど)、2−ハロゲノ
プリンリボヌクレオシド(たとえば、2−ハロゲノイノ
シン・、2−ハロゲノインシンなど)、6−ハロゲノプ
リンリボヌクレオシド(たとえば、2−アミノ−6−ハ
ロゲノプリンリボヌクレオシド、2−ヒドロキシ−6−
ハロゲノプリンリボヌクレオシドなど)など。Examples of the halogenopurine ribonucleosides include 8-halogenopurine ribonucleosides (e.g., 8-halogenoadenosine, 8-halogenoguanosine, 8-halogenoinosine, 8-halogenoxanthosine, etc.), 2-halogenopurine ribonucleosides (e.g., 2-halogenopurine ribonucleosides), halogenoinosine, 2-halogenoinsine, etc.), 6-halogenopurine ribonucleoside (e.g., 2-amino-6-halogenopurine ribonucleoside, 2-hydroxy-6-
halogenoprine ribonucleosides, etc.).
ハロゲノピリミジンリボヌクレオシドとしては5−ハロ
ゲノピリミジンリボヌクレオシド(たとえば、5−ハロ
ゲノシチジン、5−ハロゲノウリジンなど)7をそれぞ
れ挙げることができる。Examples of the halogenopyrimidine ribonucleosides include 5-halogenopyrimidine ribonucleosides (eg, 5-halogenocytidine, 5-halogenouridine, etc.) 7.
原料化合物は上記例示化合物のようなりボフラノシドに
制限されず、上記リボヌレオシドに対応する位置がハロ
ゲン化されたデオキシリボフラノシド(たとえば、2′
−デオキシリボフラノシド。The raw material compounds are not limited to bofuranosides such as the above-mentioned exemplified compounds, but include deoxyribofuranosides halogenated at the position corresponding to the above-mentioned ribonureoside (for example, 2'
-Deoxyribofuranoside.
3′−デオキシリボフラノシドなど)、アラビノフラノ
シド、キシロフラノシド、グルコフラノシドなどいずれ
のものであってもよい。3'-deoxyribofuranoside, etc.), arabinofuranoside, xylofuranoside, and glucofuranoside.
原料化合物は、糖部水酸基を保護しない無保護のもので
もよいが、適当に水酸基を保護した保護体を用いるのが
好ましい。Although the raw material compound may be an unprotected compound in which the hydroxyl group of the sugar moiety is not protected, it is preferable to use a protected compound in which the hydroxyl group is appropriately protected.
そのような保護基としては、ヌクレオシドの水酸基の保
護基として常用され、本発明方法の反応に影響を及ぼさ
ないものであればいずれのものであってもよい、具体的
には、アセチル、プロピオニル、ブチリル、ベンゾイル
、ナフトイルなどのアシル基、エチリデン、プロピリデ
ン、イソプロピリデン、ベンジリデン、シクロへキシリ
デン、シクロペンチリデン、メトキシメチリデン、エト
キシメチリデン、ジメトキシメチリデンなどのアセター
ルまたはケタール型保護基、ベンジル、p−メトキシベ
ンジル、3,4−ジメトキシベンジル、ジフェニルメチ
ル、トリフェニルメチル、αもしくはβ−ナフチルメチ
ル、α−ナフチルジフェニルメチルなどのアルアルキル
基、トリメチルシリル、t−ブチルジメチルシリル、メ
チルジイソプロピルシリル、トリイソプロピルシリル、
テトライソプロビルジシロキシル(TIPDS)などの
シリル基を例示することができ、特にシリル基が好適で
ある。As such a protecting group, any group that is commonly used as a protecting group for the hydroxyl group of a nucleoside and does not affect the reaction of the method of the present invention may be used. Specifically, acetyl, propionyl, Acyl groups such as butyryl, benzoyl, naphthoyl, acetal or ketal type protecting groups such as ethylidene, propylidene, isopropylidene, benzylidene, cyclohexylidene, cyclopentylidene, methoxymethylidene, ethoxymethylidene, dimethoxymethylidene, benzyl, p -Aralkyl groups such as methoxybenzyl, 3,4-dimethoxybenzyl, diphenylmethyl, triphenylmethyl, α- or β-naphthylmethyl, α-naphthyldiphenylmethyl, trimethylsilyl, t-butyldimethylsilyl, methyldiisopropylsilyl, triisopropyl Cyril,
Examples include silyl groups such as tetraisoprobyl disiloxyl (TIPDS), and silyl groups are particularly preferred.
本発明方法は、このような原料化合物とトリアルキルア
ルミニウム試薬とをパラジウム触媒の存在下で反応させ
る方法である。The method of the present invention is a method in which such a raw material compound and a trialkylaluminium reagent are reacted in the presence of a palladium catalyst.
トリアルキルアルミニウム試薬は、導入するアルキル基
に対応したアルキル基を有するものを使用する。このよ
うなトリアルキルアルミニウム試薬を具体的に例示すれ
ば、トリメチルアルミニウム、トリエチルアルミニウム
、トリーn−プロビリアルミニウム、トリーミープロピ
ルアルミニウム、トリーn−ブチルアルミニウム、トリ
ーi −ブチルアルミニウム、トリーt−ブチルアルミ
ニウム、トリシクロプロピルアルミニウムなどを挙げる
ことができる。トリアルキルアルミニウム試薬の多くは
市販されており、該市販品を利用すればよい。The trialkylaluminum reagent used has an alkyl group corresponding to the alkyl group to be introduced. Specific examples of such trialkylaluminum reagents include trimethylaluminum, triethylaluminum, tri-n-probylyaluminum, tri-propylaluminum, tri-n-butylaluminum, tri-i-butylaluminum, tri-t-butylaluminum. , tricyclopropyl aluminum, and the like. Many of the trialkylaluminum reagents are commercially available, and these commercially available products may be used.
パラジウム触媒としては、ビス(アセトニトリル)パラ
ジウムジクロライド、ビス(トリフェニルホスフィン)
パラジウムジクロライド、ビス(ベンゾニトリル)パラ
ジウムジクロライド、テトラキス(トリフェニルホスフ
ィン)パラジウム、パラジウムジクロライドとトリフェ
ニルホスフィンの組み合わせなどを使用することができ
る。Palladium catalysts include bis(acetonitrile)palladium dichloride, bis(triphenylphosphine)
Palladium dichloride, bis(benzonitrile)palladium dichloride, tetrakis(triphenylphosphine)palladium, a combination of palladium dichloride and triphenylphosphine, and the like can be used.
反応溶媒としては、トリエチルアミン、トリブチルアミ
ン、ジメチルアニリン、ジエチルアニリン、ピリジンな
どの塩基性溶媒、テトラヒドロフラン、ジオキサンなど
のエーテル系溶媒、アセトニトリル、ジメチルホルムア
ミド、ジメチルスルホキシドなどの単独または混合溶媒
を使用することができる。As the reaction solvent, basic solvents such as triethylamine, tributylamine, dimethylaniline, diethylaniline, and pyridine, ether solvents such as tetrahydrofuran and dioxane, and single or mixed solvents such as acetonitrile, dimethylformamide, and dimethylsulfoxide can be used. can.
反応は、ハロゲノヌクレオシド1モルに対して1〜5倍
当量、好ましくは2〜4倍当量のトリアルキルアルミニ
ウム試薬および、触媒量(1〜11Qmmo1%程度)
のパラジウム触媒を用いて、反応溶媒中1反応温度30
℃〜溶媒還流温度で1〜100時間反応させることによ
り実施することができる。また1反応をアルゴンなどの
不活性ガス気流下で行えばより収率よく進行する。The reaction is carried out using a trialkylaluminum reagent in an amount of 1 to 5 times equivalent, preferably 2 to 4 times equivalent, per mole of halogenonucleoside, and a catalyst amount (about 1% to 11Qmmol).
1 reaction temperature in the reaction solvent using a palladium catalyst of 30
It can be carried out by reacting for 1 to 100 hours at a temperature of .degree. C. to solvent reflux. Furthermore, if one reaction is carried out under a stream of inert gas such as argon, the reaction will proceed with better yield.
反応後、単離精製および必要により保護基の除去処理を
施して目的化合物を得る。After the reaction, the desired compound is obtained by isolation and purification and, if necessary, removal of protecting groups.
単離精製は、ヌクレオシドに汎用されている方法(たと
えば、吸着クロマトグラフィー、再結晶法など)を適宜
選択して行えばよい。Isolation and purification may be carried out by appropriately selecting a method commonly used for nucleosides (eg, adsorption chromatography, recrystallization method, etc.).
また、保護基の除去も、使用した保護基で常用されてい
る方法を採用することができ、たとえば。Furthermore, for the removal of the protecting group, a method commonly used for the protecting group used can be employed, for example.
シリル基の場合には、フッ化アンモニウム処理、アルカ
リ性加水分解などを用いればよい。In the case of a silyl group, ammonium fluoride treatment, alkaline hydrolysis, etc. may be used.
本発明方法は、入手容易なハロゲノヌクレオシドを原料
化合物とし、該ハロゲノヌクレオシドをパラジウム触媒
の存在下トリアルキルアルミニウムとクロスカップリン
グ反応させるという極めて簡便な方法により収率よく、
目的とする化合物を得ることができる。このため、極め
て汎用性の広いヌクレオシドのアルキル化方法である。The method of the present invention uses an easily available halogenonucleoside as a raw material compound, and uses an extremely simple method of cross-coupling the halogenonucleoside with a trialkylaluminium in the presence of a palladium catalyst to achieve high yields.
The desired compound can be obtained. Therefore, it is an extremely versatile method for alkylating nucleosides.
実施例 1
〔式中、Rはアルキル基を示す、以下同様〕8−ブロモ
アデノシン誘導体(X=OHまたはH) (L mm
ola)と硫酸アンモニウム(5■)をヘキサメチルジ
シラザン(HMDS)(20aI2)に混合して、無水
条件下120℃で原料がHMDSに溶解するまで加熱し
た。Example 1 [In the formula, R represents an alkyl group, the same applies hereinafter] 8-bromoadenosine derivative (X=OH or H) (L mm
ola) and ammonium sulfate (5■) were mixed with hexamethyldisilazane (HMDS) (20aI2) and heated at 120°C under anhydrous conditions until the raw materials were dissolved in HMDS.
反応後、反応液を濾過して硫酸アンモニウムを取り除き
、濾液を減圧下留去した。残渣に5mmole%パラジ
ウム触媒〔パラジウムジクロライドとトリフェニルホス
フィンの組み合わせ(PdC1゜+2PPh、) (
A)またはテトラキス(トリフェニルホスフィン)パラ
ジウムcpa (PPha)J (B) )およびテ
トラヒドロフラン40III2を加えアルゴン気流下加
熱還流し、数分後、トリアルキルアルミニウム試薬(A
IR,) (2〜4当量)を注射器でセプタムを通して
加え加熱還流した。反応の終了の判定は原料の消失を薄
層クロマトグラフィー(TLC)にて確認することによ
った(展開液:クロロホルム/メタノール=10:1.
ベンゼン/酢酸エチル=3=7で確認)。反応液をクロ
ロホルム/水にてよく振盪してクロロホルム層をセライ
トにて処理し、溶媒を減圧上留去した。残渣をメタノー
ル(約100mg)に溶解させ、この中に塩化アンモニ
ウム水溶液(塩化アンモニウム6 mmoleを水5−
に溶解させたもの)を滴下し、3時間加熱還流した0反
応液を減圧上留去し、カラムクロマトグラフィー(展開
溶媒:クロロホルム/メタノール=5:1.担体:ワコ
ーゲノL5’C−s o 。After the reaction, the reaction solution was filtered to remove ammonium sulfate, and the filtrate was distilled off under reduced pressure. 5 mmole% palladium catalyst [combination of palladium dichloride and triphenylphosphine (PdC1°+2PPh,)] was added to the residue (
A) or tetrakis(triphenylphosphine)palladium cpa (PPha)
IR, ) (2-4 eq.) was added through the septum with a syringe and heated to reflux. The completion of the reaction was determined by confirming the disappearance of the raw materials by thin layer chromatography (TLC) (developing solution: chloroform/methanol = 10:1.
(Confirmed with benzene/ethyl acetate = 3 = 7). The reaction solution was thoroughly shaken with chloroform/water, the chloroform layer was treated with Celite, and the solvent was distilled off under reduced pressure. The residue was dissolved in methanol (approximately 100 mg), and an aqueous ammonium chloride solution (6 mmole of ammonium chloride was added to 5 mmoles of water) in methanol (approximately 100 mg).
The reaction solution was heated under reflux for 3 hours, and the reaction solution was distilled off under reduced pressure, followed by column chromatography (developing solvent: chloroform/methanol = 5:1. Support: Wakogeno L5'C-so).
(和光純薬工業−Iりまたはフロリジ/L@(キシダ化
学@11) )にて目的物を単離精製し、8−アルキル
アデノシン誘導体を得た。(Wako Pure Chemical Industries-I or Florigi/L@(Kishida Kagaku@11)) to isolate and purify the target product to obtain an 8-alkyladenosine derivative.
第1表
Et:エチル 1−Bu:i−ブチル?
1)鴫−i−ブチルアデノシン
(パラジウム触媒としてPdC1,15mole%およ
びPPh、 30 ffi船1e%を使用)
’H−NMR(DMSO−d、)
δ: 8.08 (IH,s、H−2)7.32 (2
H,brs、NH,)
5.99 (IH,m、0H)
5.78 (LH,d、J=7.32Hz、H1’ )
5.38 (IH,d、0世
5.25 (IH,d、0H)
4.96 (LH,m、H−2’ )
4.18 (LH,brs、H−3’ )4.03 (
LH,brs、H−4’ )3.75−3.42 (2
H,m、H−5’ )2、78 (2H= rn−−C
$CH(CHJJ2、19 (LH,m、 −CH,C
Q((:)!、)、)0、99 (6H,d、 J=6
.35)1z、 −CM、CH(CH,)り元素分析
C1,H,I□N、 O,・115C,H,OHとじて
2、95 (2H,’! J=7.70Hz、 −C
社、CH,)2.19 (LH,m、H−2’ )
1、33 (3H,t、 J=7.70Hz、 −CH
,C1,)元素分析 C□3Hユ? Ni o3として
実施例 2
2)2’−7’オキシ−8−二チルアデノシン1H−N
MR(DMSO−d、)
δ: 8.08 (LH,s、H−2)7、21 (2
H,brs、 NH,)6.29 (IH,t、J=7
.26Hz、H−1’ )5.60 (LH,m、0H
)
5.32 (IH,d、0H)
4.49 (IH,brs、H−3’ )3、92 (
IH,brs、 H−4’ )3.71−3.50 (
2H,m、H−5’ )3.12 (IH,m、H−2
’ )
2−ブロモアデノシン(1mmole)と硫酸アンモニ
ウム(5■)をHMDS (20IIjりに混合して、
無水条件下120℃で原料がHMDSに溶解するまで加
熱した0反応後1反応液を濾過して硫酸アンモニウムを
取り除き、濾液を減圧上留去した。残渣に5膳■ale
%パラジウム触媒〔バラジウムシクロライドとトリフェ
ニルホスフィンの組み合わせ(PdC1□+2PPh3
) (A)またはテトラキス(トリフェニルホスフィン
)パラジウム(Pd(PPb3)、)(B) )および
テトラヒドロフラン40mMを加えアルゴン気流下加熱
還流し、数分後、トリアルキルアルミニウム試薬(AI
R,)(2〜4当量)を注射器でセプタムを通して加え
加熱還流した。Table 1 Et: Ethyl 1-Bu: i-Butyl? 1) H-NMR (DMSO-d,) δ: 8.08 (IH,s, H-2 )7.32 (2
H, brs, NH,) 5.99 (IH, m, 0H) 5.78 (LH, d, J=7.32Hz, H1')
5.38 (IH, d, 0th generation 5.25 (IH, d, 0H) 4.96 (LH, m, H-2') 4.18 (LH, brs, H-3') 4.03 (
LH, brs, H-4') 3.75-3.42 (2
H, m, H-5')2,78 (2H= rn--C
$CH(CHJJ2, 19 (LH,m, -CH,C
Q((:)!,),)0,99 (6H,d, J=6
.. 35) Elemental analysis of 1z, -CM, CH(CH,)
C1,H,I□N, O,・115C,H,OH total 2,95 (2H,'! J=7.70Hz, -C
company, CH,)2.19 (LH,m,H-2') 1,33 (3H,t, J=7.70Hz, -CH
,C1,) Elemental analysis C□3Hyu? Example 2 as Ni o3 2) 2'-7'oxy-8-dithyadenosine 1H-N
MR (DMSO-d,) δ: 8.08 (LH, s, H-2) 7, 21 (2
H, brs, NH, )6.29 (IH, t, J=7
.. 26Hz, H-1')5.60 (LH,m,0H
) 5.32 (IH, d, 0H) 4.49 (IH, brs, H-3') 3,92 (
IH, brs, H-4') 3.71-3.50 (
2H,m,H-5')3.12 (IH,m,H-2
) 2-bromoadenosine (1 mmole) and ammonium sulfate (5 mm) were mixed in HMDS (20 mmole),
After 0 reactions in which the raw materials were heated at 120° C. under anhydrous conditions until they were dissolved in HMDS, the 1 reaction solution was filtered to remove ammonium sulfate, and the filtrate was distilled off under reduced pressure. 5 servings of ale on the residue
% palladium catalyst [combination of palladium cyclolide and triphenylphosphine (PdC1□+2PPh3
) (A) or tetrakis(triphenylphosphine)palladium (Pd(PPb3), )(B) ) and 40 mM of tetrahydrofuran were added and heated to reflux under an argon atmosphere. After a few minutes, trialkylaluminum reagent (AI
R,) (2-4 eq.) was added through the septum with a syringe and heated to reflux.
反応の終了の判定は原料の消失をTLCにて確認するこ
とによった(展開液:クロロホルム/メタノール=10
:l、ベンゼン/酢酸エチル=3ニアで確認)。反応液
をクロロホルム/水にてよく振盪してクロロホルム層を
セライトにて処理し、溶媒を減圧上留去した。残渣をメ
タノール(約100d)に溶解させ、この中に塩化アン
モニウム水溶液(塩化アンモニウム6 mmoleを水
5−に溶解させたもの)を滴下し、3時間加熱還流した
。The completion of the reaction was determined by confirming the disappearance of the raw materials by TLC (developing solution: chloroform/methanol = 10
:l, confirmed with benzene/ethyl acetate = 3nia). The reaction solution was thoroughly shaken with chloroform/water, the chloroform layer was treated with Celite, and the solvent was distilled off under reduced pressure. The residue was dissolved in methanol (about 100 d), and an aqueous ammonium chloride solution (6 mmole of ammonium chloride dissolved in 5 mm of water) was added dropwise thereto, and the mixture was heated under reflux for 3 hours.
反応液を減圧上留去し、カラムクロマトグラフィー(展
開溶媒:クロロホルム/メタノール=5:1、担体:ワ
コーゲルC−300またはフロリジル)にて目的物を単
離精製し、2−アルキルアデノシン誘導体を得た。The reaction solution was distilled off under reduced pressure, and the target product was isolated and purified using column chromatography (developing solvent: chloroform/methanol = 5:1, carrier: Wakogel C-300 or Florisil) to obtain a 2-alkyladenosine derivative. Ta.
1) 、 2) 、 3)の化合物は融点の代わりにM
Sおよび1H−NMR(DMSO−d、)の測定値を記
す。Compounds 1), 2), and 3) have M instead of melting point.
Measured values of S and 1H-NMR (DMSO-d,) are shown.
1)2−エチルアデノシン
MS: 295 (M”)
’H−NMR
δ: 8.27 (IH,s、H−8)7.27 (2
H,brs、N旦2)
5.87 (IH,d、J=6.83Hz、H−1’
)5.68 (LH,m、0H)
5.43 (IH,む0H)
5.21 (LH,m、0H)
4.69 (LH,dd、J=11.72,6.831
(z、H−2’ )4.18 (IH,brs、H−3
’ )4.00 (IH,brs、H−4’ )3.7
4−3.42 (2H,m、H−5’ )2、67 (
2H,C1,J=++7.81Hz、 −CH,CH,
)1、25 (3H,t、 J=7.81Hz、 −C
H,CMJ)2)2−n−プロピルアデノシン
MS : 309 (M”)
’H−NMR
δ: 8.26 (LH,s、H−8)7.27 (2
H,brs= NHJ
5゜86 (IH,d、J=6.844!z、H−1’
)5.73 (1H,m、O旦)
5.43 (LH,d、0H)
5.20 (IH,d、O!lり
4.69 (LH,dd、J=11.72,6.84)
tz、H−2’ )4、16 (LH,brs、 H−
3’ )4、00 (LH,brs、 H−4’ )3
.74−3.53 (2H,m、H−5’ )2、83
<2H−t−J=7.32)tz2%CHzCHs)
1、74 (2H,m、 −CH,CH,CH,)0、
93 (3)f、’ t、 J=7.32H1,−CH
,CH,C33)3)2−i−ブチルアデノシン
MS: 323 (M+)
”H−NMR
δ:8.26 (IH,s、H−8)
7、27 (2H,brs、 N!12)5.86 (
LH,d、J=6.84Hz、H−1’ )5.80
(IH,m、O旦)
5.43 (LH,d、0H)
5.21 (IH,d、○W
4.69 (IH,dd、J=11.72,6.84H
z、H−2’ )4゜1.6 (IH,brs、 H−
3’ )4、00 (LH,hrs、 H−4’ )3
.72−3.50 (2H,m、H−5’ )2、52
(2H,m、 −C!!、CH(C1,)、)2、1
7 (IH,m、 −CH,CH(CI、)、)0、9
0 (6H,d、 J =6.35Hz、 −(H,C
H(CiiI)2)実施例 3
8−ブロモグアノシン(1鳳mole)と硫酸アンモニ
ウム(5!1g)をHMDS (20d)に混合して、
無水条件下120℃で原料がHMDSに溶解するまで加
熱した1反応後、反応液を濾過して硫酸アンモニウムを
取り除き濾液を減圧上留去した。1) 2-Ethyladenosine MS: 295 (M”) 'H-NMR δ: 8.27 (IH, s, H-8) 7.27 (2
H,brs,Ndan2) 5.87 (IH,d,J=6.83Hz,H-1'
) 5.68 (LH, m, 0H) 5.43 (IH, m0H) 5.21 (LH, m, 0H) 4.69 (LH, dd, J=11.72, 6.831
(z, H-2')4.18 (IH, brs, H-3
' ) 4.00 (IH, brs, H-4' ) 3.7
4-3.42 (2H,m,H-5')2,67 (
2H,C1,J=++7.81Hz, -CH,CH,
)1, 25 (3H, t, J=7.81Hz, -C
H, CMJ) 2) 2-n-propyladenosine MS: 309 (M”) 'H-NMR δ: 8.26 (LH, s, H-8) 7.27 (2
H,brs=NHJ 5゜86 (IH,d,J=6.844!z,H-1'
) 5.73 (1H, m, Odan) 5.43 (LH, d, 0H) 5.20 (IH, d, O!lri 4.69 (LH, dd, J=11.72, 6. 84)
tz, H-2') 4, 16 (LH, brs, H-
3')4,00 (LH,brs,H-4')3
.. 74-3.53 (2H,m,H-5')2,83
<2H-t-J=7.32)tz2%CHzCHs)
1,74 (2H,m, -CH,CH,CH,)0,
93 (3) f,' t, J=7.32H1,-CH
, CH, C33) 3) 2-i-butyladenosine MS: 323 (M+) "H-NMR δ: 8.26 (IH, s, H-8) 7, 27 (2H, brs, N!12) 5 .86 (
LH, d, J = 6.84Hz, H-1') 5.80
(IH, m, Odan) 5.43 (LH, d, 0H) 5.21 (IH, d, ○W 4.69 (IH, dd, J=11.72, 6.84H
z, H-2')4゜1.6 (IH, brs, H-
3')4,00 (LH,hrs, H-4')3
.. 72-3.50 (2H,m,H-5')2,52
(2H,m, -C!!,CH(C1,),)2,1
7 (IH,m, -CH,CH(CI,),)0,9
0 (6H, d, J = 6.35Hz, -(H,C
H(Ciii)2) Example 3 8-bromoguanosine (1 mole) and ammonium sulfate (5!1 g) were mixed in HMDS (20d),
After one reaction in which the raw materials were heated at 120° C. under anhydrous conditions until they were dissolved in HMDS, the reaction solution was filtered to remove ammonium sulfate, and the filtrate was distilled off under reduced pressure.
残渣に5 mmols%パラジウム触媒〔パラジウムジ
クロライドとトリフェニルホスフィンの組み合わせ(P
dC1□+2PPhi ) (A )またはテトラキ
ス(トリフェニルホスフィン)パラジウム(Pd(PP
h、)、)(B)〕およびテトラヒドロフラン40−を
加えアルゴン気流下加熱還流し、数分後、トリメチルア
ルミニウム(2〜4当量)を注射器でセプタムを通して
加え24時間加熱還流した。反応の終了の判定は原料の
消失をTLCにで確認することによった(展開液:クロ
ロホルム/メタノール=10:1.ベンゼン/酢酸エチ
ル=3ニアで確認)。5 mmols% palladium catalyst [a combination of palladium dichloride and triphenylphosphine (P
dC1□+2PPhi) (A) or tetrakis(triphenylphosphine)palladium (Pd(PP
h, ), )(B)] and tetrahydrofuran 40- were added and heated to reflux under an argon atmosphere. After a few minutes, trimethylaluminum (2 to 4 equivalents) was added through the septum with a syringe and heated to reflux for 24 hours. The completion of the reaction was determined by confirming the disappearance of the raw materials using TLC (developing solution: chloroform/methanol = 10:1; benzene/ethyl acetate = 3N).
反応液をクロロホルム/水にてよく振盪してクロロホル
ム層をセライトにて処理し、溶媒を減圧上留去した。残
渣をメタノール(ioo−)に溶解させ、この中に塩化
アンモニウム水溶液(塩化アンモニウム6 mmole
を水5−に溶解させたもの)を0滴下し、3時間加熱還
流した。反応液を減圧上留去し、カラムクロマトグラフ
ィー(展開溶媒:クロロホルム/メタノール=5:1.
担体:ワコーゲルC−300またはフロリジル)にて目
的物を単離精製し、8−メチルグアノシンを得た。The reaction solution was thoroughly shaken with chloroform/water, the chloroform layer was treated with Celite, and the solvent was distilled off under reduced pressure. The residue was dissolved in methanol (ioo-), and an aqueous ammonium chloride solution (6 mmole of ammonium chloride) was added thereto.
(dissolved in water) was added dropwise, and the mixture was heated under reflux for 3 hours. The reaction solution was distilled off under reduced pressure and subjected to column chromatography (developing solvent: chloroform/methanol = 5:1.
The target product was isolated and purified using a carrier (Wakogel C-300 or Florisil) to obtain 8-methylguanosine.
結果を第3表に示す。The results are shown in Table 3.
第3表
実施例 4
2−アミノ−6−クロロプリン−9−リボシド(1ga
ole)と硫酸アンモニウム(5■)をHMDS (2
0ail)に混合して、無水条件下120℃で原料がH
MDSに溶解するまで加熱した1反応後、反応液を濾過
して硫酸アンモニウムを取り除き濾液を減圧上留去した
。残渣に5 +ueole%パラジウム触媒〔パラジウ
ムジクロライドとトリフェニルホスフィンとの組み合わ
せ(PdC1,+2PPh、)(A)またはテトラキス
(トリフェニルホスフィン)パラジウム(Pd(PPh
i)4)(B) )およびテトラヒドロフラン40al
lを加えアルゴン気流下加熱還流し、数分後、トリメチ
ルアルミニウム(2〜4当量)を注射器でセプタムを通
して加え加熱還流した8反応の終了の判定は原料の消失
をTLCにて確認することによった(展開液:クロロホ
ルム/メタノール=10:1.ベンゼン/酢酸エチル=
3ニアで確認)0反応液をクロロホルム/水にてよく振
盪してクロロホルム層をセライトにて処理して減圧上留
去した。残渣をメタノール(100atff)に溶解さ
せ、この中に塩化アンモニウム水溶液(塩化アンモニウ
ム6 mmoleを水511I2に溶解させたもの)を
滴下し、3時間加熱還流した。Table 3 Example 4 2-amino-6-chloropurine-9-riboside (1 ga
ole) and ammonium sulfate (5) in HMDS (2
0ail), and the raw materials were heated to 120°C under anhydrous conditions.
After one reaction in which the mixture was heated until dissolved in MDS, the reaction solution was filtered to remove ammonium sulfate, and the filtrate was distilled off under reduced pressure. The residue contains 5+ueole% palladium catalyst [a combination of palladium dichloride and triphenylphosphine (PdC1,+2PPh,) (A) or tetrakis(triphenylphosphine)palladium (Pd(PPh)
i) 4) (B) ) and tetrahydrofuran 40al
After a few minutes, trimethylaluminum (2 to 4 equivalents) was added through the septum with a syringe and heated to reflux. 8 The completion of the reaction was determined by checking the disappearance of the raw materials by TLC. (Developing solution: chloroform/methanol = 10:1. Benzene/ethyl acetate =
The reaction solution was thoroughly shaken with chloroform/water, the chloroform layer was treated with Celite, and the mixture was distilled off under reduced pressure. The residue was dissolved in methanol (100 atff), and an aqueous ammonium chloride solution (6 mmole of ammonium chloride dissolved in 511 I2 of water) was added dropwise thereto, and the mixture was heated under reflux for 3 hours.
反応液を減圧上留去し、カラムクロマトグラフィー(展
開溶媒:クロロホルム/メタノール=5=1、担体:ワ
コーゲルC−300また・はフロリジル)にて目的物を
単離精製し、2−アミノ−6−メチルプリン−9−リボ
シドを得た。The reaction solution was distilled off under reduced pressure, and the target product was isolated and purified by column chromatography (developing solvent: chloroform/methanol = 5 = 1, carrier: Wakogel C-300 or Florisil), and 2-amino-6 -Methylpurine-9-riboside was obtained.
結果を第4表に示す。The results are shown in Table 4.
第4表
実施例 5
5−ブロモウリジン誘導体(X=OH,Y=H1X=Y
=HまたはX=H,Y=OH) (liuiole)
と硫酸アンモニウム(5■)をHMDS (20d)に
混合して、無水条件下120℃で原料がHMDSに溶解
するまで加熱した0反応後、反応液を濾過して硫酸アン
モニウムを取り除き濾液を減圧上留去した。残渣に5鳳
謹o1a%パラジウム触媒〔パラジウムジクロライドと
トリフェニルホスフィンの組み合わせ(PdC1i +
2PPhi) (A)またはテトラキス(トリフェニ
ルホスフィン)パラジウム(Pd(PPh3)4)(B
))およびテトラヒドロフラン40−を加えアルゴン
気流下加熱還流し、数分後。Table 4 Example 5 5-bromouridine derivative (X=OH, Y=H1X=Y
=H or X=H, Y=OH) (liuiole)
and ammonium sulfate (5■) were mixed with HMDS (20d) and heated at 120°C under anhydrous conditions until the raw materials were dissolved in HMDS. After the reaction, the reaction solution was filtered to remove ammonium sulfate and the filtrate was distilled off under reduced pressure. did. The residue was 50% O1a% palladium catalyst [a combination of palladium dichloride and triphenylphosphine (PdC1i +
2PPhi) (A) or tetrakis(triphenylphosphine)palladium (Pd(PPh3)4) (B
)) and tetrahydrofuran 40- were added and heated to reflux under an argon atmosphere, after several minutes.
トリメチルアルミニウム(2〜4当量)を注射器でセプ
タムを通して加え加熱還流した0反応の終了の判定は原
料の消失をTLCにて確認することによった(展開液:
クロロホルム/メタノール=10:1.ベンゼン/酢酸
エチル=3=7で確認)。Trimethylaluminum (2 to 4 equivalents) was added through the septum with a syringe and heated to reflux. The completion of the reaction was determined by confirming the disappearance of the raw material by TLC (Developing solution:
Chloroform/methanol = 10:1. (Confirmed with benzene/ethyl acetate = 3 = 7).
反応液をクロロホルム/水にてよく振盪してクロロホル
ム層をセライトにて処理し、溶媒を減圧上留去した。残
渣をメタノール(100mりに溶解させ、この中にテト
ラブチルアンモニウムフルオライドを滴下し、室温下1
〜2時間反応させた。The reaction solution was thoroughly shaken with chloroform/water, the chloroform layer was treated with Celite, and the solvent was distilled off under reduced pressure. The residue was dissolved in methanol (100ml), tetrabutylammonium fluoride was added dropwise to this solution, and the mixture was heated at room temperature for 1 hour.
Allowed to react for ~2 hours.
反応液を減圧上留去し、カラムクロマトグラフィー(展
開溶媒:クロロホルム/メタノール=5=1、担体:ワ
コーゲルC−300またはフロリジル)にて目的物を単
離精製し、5−アルキルウリジン誘導体を得た。The reaction solution was distilled off under reduced pressure, and the target product was isolated and purified using column chromatography (developing solvent: chloroform/methanol = 5 = 1, carrier: Wakogel C-300 or Florisil) to obtain a 5-alkyluridine derivative. Ta.
結果を第5表に示す。The results are shown in Table 5.
実施例 6 5−ヨードウリジン誘導体(X=OH,Y=H。Example 6 5-iodouridine derivative (X=OH, Y=H.
X=Y=HまたはX=H,Y=OH)(1ti+ole
)と硫酸アンモニウム(5■)をHMDS (20−)
に混合して、無水条件下120℃で原料がHMDSに溶
解するまで加熱した0反応後、反応液を濾過して硫酸ア
ンモニウムを取り除き濾液を減圧上留去した。残渣に5
+amols%パラジウム触媒〔パラジウムジクロラ
イドとトリフェニルホスフィンの組み合わせ(pdcl
、+zpph、) (A)またはテトラキス(トリフェ
ニルホスフィン)パラジウム(Pd(PPhi)4)(
B) )およびテトラヒドロフラン40−を加えアルゴ
ン気流下加熱還流し、数分後。X=Y=H or X=H, Y=OH) (1ti+ole
) and ammonium sulfate (5■) in HMDS (20-)
After the reaction was heated at 120° C. under anhydrous conditions until the raw materials were dissolved in HMDS, the reaction solution was filtered to remove ammonium sulfate, and the filtrate was distilled off under reduced pressure. 5 for residue
+amols% palladium catalyst [combination of palladium dichloride and triphenylphosphine (pdcl
, +zpph, ) (A) or tetrakis(triphenylphosphine)palladium (Pd(PPhi)4)(
B)) and tetrahydrofuran 40- were added and heated to reflux under an argon atmosphere, after several minutes.
トリアルキルアルミニウム試薬(AIR,) (2〜4
当量)を注射器でセプタムを通して加え加熱還流した0
反応の終了の判定は原料の消失をTLCにて確認するこ
とになった(展開液:クロロホルム/メタノール=10
:1.ベンゼン/酢酸エチル=3ニアで確認)0反応液
をクロロホルム/水にてよく振盪してクロロホルム層を
セライトにて処理し、溶媒を減圧上留去した。残渣をメ
タノール(100−)に溶解させ、この中に塩化アンモ
ニウム水溶液(塩化アンモニウム5 gloleを水5
−に溶解させたもの)を滴下し、3時間加熱還流した。Trialkylaluminium reagent (AIR,) (2-4
equivalent amount) was added through the septum with a syringe and heated to reflux.
The completion of the reaction was determined by confirming the disappearance of the raw materials by TLC (Developing solution: chloroform/methanol = 10
:1. The reaction solution was thoroughly shaken with chloroform/water, the chloroform layer was treated with Celite, and the solvent was distilled off under reduced pressure. The residue was dissolved in methanol (100-), and an aqueous ammonium chloride solution (5 ml of ammonium chloride was added to 5 ml of water) was dissolved in methanol (100-).
-) was added dropwise, and the mixture was heated under reflux for 3 hours.
反応液を減圧上留去し、カラムクロマトグラフィー(展
開溶媒:クロロホルム/メタノール=5:1、担体:ワ
コーゲルC−300またはフロリジル)にて目的物を単
離精製し、5−アルキルウリジン誘導体を得た。The reaction solution was distilled off under reduced pressure, and the target product was isolated and purified using column chromatography (developing solvent: chloroform/methanol = 5:1, carrier: Wakogel C-300 or Florisil) to obtain a 5-alkyluridine derivative. Ta.
結果を第6表に示す。The results are shown in Table 6.
第6表
1)5−エチルウリジン
IH−NMR(DMSO−d、)
δ: 7.76 (IH,s、H−6)5.82 (I
H,d、J=5.38Hz、H1’ )5.36 (I
H,d、○H)
5.17−5.08 (2H,m、2XOH)06−4
.00 (2H,m、H−2’r−H−3’86 (L
H,brs、H−4’ )Table 6 1) 5-ethyluridine IH-NMR (DMSO-d,) δ: 7.76 (IH,s, H-6) 5.82 (I
H, d, J = 5.38 Hz, H1') 5.36 (I
H, d, ○H) 5.17-5.08 (2H, m, 2XOH) 06-4
.. 00 (2H,m,H-2'r-H-3'86 (L
H, brs, H-4')
Claims (1)
キル基を導入する部位をハロゲン化したハロゲノヌクレ
オシドとトリアルキルアルミニウム試薬とをパラジウム
触媒の存在下反応させることを特徴とするヌクオシドの
アルキル化方法。1) A method for alkylating nucleosides, the method comprising reacting a halogenonucleoside whose site for introducing an alkyl group is halogenated with a trialkylaluminum reagent in the presence of a palladium catalyst.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3574689A JPH02215793A (en) | 1989-02-15 | 1989-02-15 | Alkylation of nucleoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3574689A JPH02215793A (en) | 1989-02-15 | 1989-02-15 | Alkylation of nucleoside |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02215793A true JPH02215793A (en) | 1990-08-28 |
Family
ID=12450383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3574689A Pending JPH02215793A (en) | 1989-02-15 | 1989-02-15 | Alkylation of nucleoside |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02215793A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020483A (en) * | 1998-09-25 | 2000-02-01 | Nexstar Pharmaceuticals, Inc. | Nucleoside modifications by palladium catalyzed methods |
-
1989
- 1989-02-15 JP JP3574689A patent/JPH02215793A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020483A (en) * | 1998-09-25 | 2000-02-01 | Nexstar Pharmaceuticals, Inc. | Nucleoside modifications by palladium catalyzed methods |
WO2000018780A1 (en) * | 1998-09-25 | 2000-04-06 | Nexstar Pharmaceuticals, Inc. | Nucleoside modifications by palladium catalyzed methods |
US6355787B1 (en) * | 1998-09-25 | 2002-03-12 | Gilead Sciences, Inc. | Purine nucleoside modifications by palladium catalyzed methods and compounds produced |
US6512106B2 (en) * | 1998-09-25 | 2003-01-28 | Gilead Sciences, Inc. | Nucleoside modifications by palladium catalyzed methods |
US6846918B2 (en) | 1998-09-25 | 2005-01-25 | Gilead Sciences, Inc. | Nucleoside modifications by palladium catalyzed methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ogilvie et al. | Synthesis of oligoribonucleotides | |
EP0193903B1 (en) | Production of cytosine nucleosides | |
CA2035038C (en) | Synthetic intermediates of 2-alkynyladenosines, processes for preparing the synthetic intermediates, processes for preparing 2-alkynyladenosines utilizing the synthetic intermediates, and stable 2-alkynyladenosine derivatives | |
IE62227B1 (en) | 2', 3'-Dideoxy-2' -fluoronucleosides | |
Matulic-Adamic et al. | Synthesis and Structure of 1-Deoxy-1-phenyl-bD-ribofuranose and Its Incorporation into Oligonucleotides | |
CA2029301A1 (en) | Deoxyfluoronucleoside process | |
US5633366A (en) | Pyrimidine nucleoside derivatives and methods for producing them | |
US20030060622A1 (en) | Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides | |
JPH04501558A (en) | Method for preparing 2',3'-dideoxynucleosides | |
JPH051092A (en) | Nucleoside derivative and its production | |
US5336764A (en) | 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides | |
US4691012A (en) | Sialic acid derivative and process for preparing the same | |
EIgemeie et al. | A synthetic strategy to a new class of cycloalkane ring-fused pyridine nucleosides as potential anti HIV agents | |
KR940004075B1 (en) | Novel anthracycline oerivative antitumor agent and production | |
US3558595A (en) | 2'-cyclic esters and 5'-cyclic esters of 3'-deoxy - 3' - dihydroxyphosphinylmethyl - beta - d - ribofuranosylnucleoside derivatives and intermediates therefor | |
JPH02215793A (en) | Alkylation of nucleoside | |
JPH0660189B2 (en) | 2,6-Dideoxy-2-fluoro-L-talopyranoses or derivatives thereof and method for producing the same | |
Walczak et al. | Synthesis of 1-(3-alkyl-2, 3-dideoxy-D-pentofuranosyl) uracils with potential anti-HIV activity | |
US5290927A (en) | Process for preparing 2',3'-dideoxyadenosine | |
EP0064796A2 (en) | Phosphorylating agent and process for the phosphorylation of organic hydroxyl compounds | |
Kawana et al. | The synthesis of C-methyl branched-chain deoxy sugar nucleosides by the deoxygenative methylation of O-tosylated adenosines with Grignard reagents. | |
Aralov et al. | Protective groups in the chemical synthesis of oligoribonucleotides | |
El Khadem et al. | Two crystalline pentofuranosyl bromides: tri-O-(p-nitrobenzoyl)-β-D-ribofuranosyl bromide and tri-O-(p-nitrobenzoyl)-α, β-D-xylofuranosyl bromide | |
Schmidt et al. | A New Approach to the Synthesis of 2-Aminopurine-2′-deoxyriboside via Tri-n-butyltin Hydride Reduction | |
CN1159331C (en) | Prepn. of 2',3'-didehydro-3'-deoxythymidine |